The USFDA hasΒ completed inspection of Divis LaboratoriesΒ unit-I at Choutuppal, Telangana with no 483 observations. The inspection was a general cGMP inspection by the FDA and...
Granules India hasΒ received Establishment Inspection Report (EIR), from the US health regulator for facility in Telangana. The US Food and Drug Administration inspected Jeedimetla facility...
The US health regulator has completed inspection of J B Chemicals and PharmaceuticalsΒ Panoli facility, in Gujarat with two minor observations. In a BSE filing the...
Glenmark Pharmaceuticals hasΒ received final approval for the generic version of Temovate cream used to treat inflammation and itching caused by a number of skin conditions,...
Cadila Healthcare has received final approval to market Carbidopa tablets,25 mg from USFDA. The drug is usedΒ with a combination levodopa/carbidopa product to treat symptoms of...
The US health regulator, has issued 7 observations to Biocon’sΒ sterile drug product manufacturing facility in Bengaluru, after inspection. In a filing to the BSE the...
Zydus Cadila has received final approvalΒ to market two drugs,Β from the US health regulator. The company stated that, it has received approval to marketΒ Methylprednisolone tablets USP...
Lupin has received final approvalΒ to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....
The US health regulator has completed the inspection of Unichem’s Laboratories,Β Ghaziabad facility in Uttar Pradesh and the regulator has not issued any observation to it....
Glenmark Pharmaceuticals has received final approval forΒ generic version of Temovate Topical Solution, from the US health regulator. It is used to treatΒ certain scalp and skin...